Compare Gigacloud Technology Inc (GCT) vs Kymera Therapeutics Inc. Common Stock (KYMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gigacloud Technology Inc vs Kymera Therapeutics Inc. Common Stock — how do they compare? Gigacloud Technology Inc trades at $57.54 (market cap $2.04B), while Kymera Therapeutics Inc. Common Stock trades at $106.9 (market cap $8.87B). The key difference: Kymera Therapeutics Inc. Common Stock is far larger — about 4.3× Gigacloud Technology Inc's market cap, and Gigacloud Technology Inc is trading nearer its 52-week high, Kymera Therapeutics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Gigacloud Technology Inc for 20 Days and Kymera Therapeutics Inc. Common Stock for 0 Days on average.
| GCT | KYMR | |
|---|---|---|
Market Cap | $2.04B | $8.87B |
Volume | 633,969 | 779,107 |
Sector | Technology | Health |
52-Week High | $57.75 | $127.31 |
52-Week Low | $25.46 | $55.80 |
Typical Hold Time | 20 Days | 0 Days |
Enterprise Value | $2.16B | $8.26B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GCT trades at $57.03, down 1.23% today, with a bullish technical outlook from moving averages but bearish oscillators. The company demonstrates strong fundamentals with consistent earnings beats, 10.65% net margins, and robust 32.34% ROE. Recent news highlights institutional interest and analyst optimism despite insider selling activity. Revenue growth continues with 2026 projections showing $1.5B revenue and maintained profitability.
GCT presents a compelling investment case with attractive valuation multiples (P/E 13.58) and strong execution, though technical indicators show overbought conditions. Key risks include market volatility and competitive pressures, but analyst consensus remains bullish with 66.7% buy ratings and $32.50 price target suggesting significant upside potential from current levels.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Gigacloud Technology Inc
Gigacloud Technology operates a global B2B e-commerce marketplace for large-parcel goods. It provides a comprehensive solution for furniture manufacturers and retailers with integrated logistics and fulfillment.
Read more on GCT →About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →
